Kura Oncology, Inc. (KURA) Stock Price

KURAStock

$13.59+62.09%52W

Market Cap$1.21B

P/E—

PEG Ratio—

Div yield—

Beta0.43

KURA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)34.81%

Price vs S&P 500 (4W)30.14%

VGM Score61.08

P/CF (Annual)5.80x

Book Value / Share (Quarterly)$1.22

P/TBV (Annual)1.69x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.95

Price vs S&P 500 (YTD)7.39%

Net Profit Margin (TTM)-411.19%

EPS (TTM)$-3.35

10-Day Avg Trading Volume2.55M

EPS Excl Extra (TTM)$-3.35

EPS (Annual)$-3.18

ROI (Annual)-151.58%

Gross Margin (Annual)99.92%

Cash / Share (Quarterly)$6.50

Revenue Growth QoQ (YoY)29.47%

ROA (Last FY)-37.74%

EBITD / Share (TTM)$-3.60

ROE (5Y Avg)-59.72%

Operating Margin (TTM)-443.54%

Cash Flow / Share (Annual)$-0.80

P/B Ratio8.48x

P/B Ratio (Quarterly)6.66x

Net Income / Employee (Annual)$-1,071,800

EV / Revenue (TTM)12.37x

Net Interest Coverage (TTM)-252.07x

ROA (TTM)-43.28%

EPS Incl Extra (Annual)$-3.18

Current Ratio (Annual)6.06x

Quick Ratio (Quarterly)5.81x

3-Month Avg Trading Volume1.75M

52-Week Price Return62.09%

EV / Free Cash Flow (Annual)5.19x

Revenue / Employee (TTM)$275,500

Tangible BV / Share (Quarterly)$5.79

P/S Ratio (Annual)13.56x

Asset Turnover (Annual)0.09x

52-Week High$12.90

EPS Excl Extra (Annual)$-3.18

CapEx CAGR (5Y)25.06%

Tangible BV CAGR (5Y)39.39%

26-Week Price Return46.05%

Quick Ratio (Annual)5.78x

13-Week Price Return11.41%

Total Debt / Equity (Annual)0.06x

Current Ratio (Quarterly)6.15x

Enterprise Value$885.93M

Asset Turnover (TTM)0.11x

Book Value / Share Growth (5Y)-26.48%

Revenue / Employee (Annual)$259,500

Pretax Margin (Annual)-412.51%

Cash / Share (Annual)$7.55

3-Month Return Std Dev61.67%

Net Income / Employee (TTM)$-1,133,000

ROE (Last FY)-160.03%

Net Interest Coverage (Annual)-122.19x

EPS Basic Excl Extra (Annual)$-3.18

Receivables Turnover (TTM)2.47x

EV / Free Cash Flow (TTM)8.35x

Total Debt / Equity (Quarterly)0.09x

EPS Incl Extra (TTM)$-3.35

ROI (TTM)-135.62%

P/S Ratio (TTM)12.78x

Revenue / Share (Annual)$0.77

Tangible BV / Share (Annual)$6.15

Price vs S&P 500 (52W)43.78%

Year-to-Date Return19.35%

5-Day Price Return0.57%

EPS Normalized (Annual)$-3.18

ROA (5Y Avg)-29.77%

Net Profit Margin (Annual)-412.95%

Month-to-Date Return37.62%

Cash Flow / Share (TTM)$-2.01

EBITD / Share (Annual)$-3.45

Operating Margin (Annual)-449.94%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)8.88x

ROI (5Y Avg)-57.52%

LT Debt / Equity (Quarterly)0.09x

EPS Basic Excl Extra (TTM)$-3.35

P/TBV (Quarterly)1.65x

P/B Ratio (Annual)5.19x

Pretax Margin (TTM)-411.08%

Book Value / Share (Annual)$1.98

Price vs S&P 500 (13W)8.62%

Beta0.43x

P/FCF (Annual)6.84x

Revenue / Share (TTM)$0.81

ROE (TTM)-141.95%

52-Week Low$7.36

vGradeC

gGradeB

mGradeB

vgmGradeB

KURA Earnings Surprise History

Q2 25-0.75est. -0.37

Q3 25-0.85est. -0.68

Q4 25-0.92est. -0.49

Q2 26-0.77est. -0.88

KURA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
KURAKura Oncology, Inc.	C	B	B	$13.59
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Kura Oncology, Inc.

Kura Oncology is a clinical-stage biopharmaceutical company focused on developing precision oncology therapies. Its pipeline comprises small molecule drug candidates designed to target specific cancer signaling pathways.